210 related articles for article (PubMed ID: 25708651)
1. Genome-wide microarray analysis of gene expression profiling in major depression and antidepressant therapy.
Lin E; Tsai SJ
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():334-40. PubMed ID: 25708651
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association studies in pharmacogenomics of antidepressants.
Lin E; Lane HY
Pharmacogenomics; 2015; 16(5):555-66. PubMed ID: 25916525
[TBL] [Abstract][Full Text] [Related]
3. The inflammatory cytokines: molecular biomarkers for major depressive disorder?
Martin C; Tansey KE; Schalkwyk LC; Powell TR
Biomark Med; 2015; 9(2):169-80. PubMed ID: 24524646
[TBL] [Abstract][Full Text] [Related]
4. Gene expression: biomarker of antidepressant therapy?
Menke A
Int Rev Psychiatry; 2013 Oct; 25(5):579-91. PubMed ID: 24151803
[TBL] [Abstract][Full Text] [Related]
5. Emerging drugs for major depressive disorder.
Connolly KR; Thase ME
Expert Opin Emerg Drugs; 2012 Mar; 17(1):105-26. PubMed ID: 22339643
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics with antidepressants in the STAR*D study.
Lin E; Chen PS
Pharmacogenomics; 2008 Jul; 9(7):935-46. PubMed ID: 18597655
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide expression profiling of human lymphoblastoid cell lines identifies CHL1 as a putative SSRI antidepressant response biomarker.
Morag A; Pasmanik-Chor M; Oron-Karni V; Rehavi M; Stingl JC; Gurwitz D
Pharmacogenomics; 2011 Feb; 12(2):171-84. PubMed ID: 21332311
[TBL] [Abstract][Full Text] [Related]
8. Potential Use of MicroRNA for Monitoring Therapeutic Response to Antidepressants.
Belzeaux R; Lin R; Turecki G
CNS Drugs; 2017 Apr; 31(4):253-262. PubMed ID: 28290081
[TBL] [Abstract][Full Text] [Related]
9. Noncoding RNAs in Depression.
Lin R; Turecki G
Adv Exp Med Biol; 2017; 978():197-210. PubMed ID: 28523548
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide transcriptomic and biochemical profiling of major depressive disorder: Unravelling association with susceptibility, severity, and antidepressant response.
Singh P; Srivastava A; Philip L; Ahuja SK; Shivangi ; Rawat C; Kutum R; Yadav J; Sood M; Chadda RK; Dash D; Vohora D; Kukreti R
Genomics; 2024 Jan; 116(1):110772. PubMed ID: 38158140
[TBL] [Abstract][Full Text] [Related]
11. Gene × environment interactions in the prediction of response to antidepressant treatment.
Klengel T; Binder EB
Int J Neuropsychopharmacol; 2013 Apr; 16(3):701-11. PubMed ID: 23237009
[TBL] [Abstract][Full Text] [Related]
12. Differential co-expression and regulation analyses reveal different mechanisms underlying major depressive disorder and subsyndromal symptomatic depression.
Xu F; Yang J; Chen J; Wu Q; Gong W; Zhang J; Shao W; Mu J; Yang D; Yang Y; Li Z; Xie P
BMC Bioinformatics; 2015 Apr; 16():112. PubMed ID: 25880836
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomics and the mechanisms of antidepressant efficacy.
Hodgson K; Tansey KE; Powell TR; Coppola G; Uher R; Zvezdana Dernovšek M; Mors O; Hauser J; Souery D; Maier W; Henigsberg N; Rietschel M; Placentino A; Aitchison KJ; Craig IW; Farmer AE; Breen G; McGuffin P; Dobson R
Eur Neuropsychopharmacol; 2016 Jan; 26(1):105-112. PubMed ID: 26621261
[TBL] [Abstract][Full Text] [Related]
14. The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder.
Caudill MM; Hunter AM; Cook IA; Leuchter AF
Clin EEG Neurosci; 2015 Oct; 46(4):277-84. PubMed ID: 25258429
[TBL] [Abstract][Full Text] [Related]
15. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
16. Treatment of major depressive disorder and dysthymic disorder with antidepressants in patients with comorbid opiate use disorders enrolled in methadone maintenance therapy: a meta-analysis.
Pedrelli P; Iovieno N; Vitali M; Tedeschini E; Bentley KH; Papakostas GI
J Clin Psychopharmacol; 2011 Oct; 31(5):582-6. PubMed ID: 21869696
[TBL] [Abstract][Full Text] [Related]
17. Value of genetic and epigenetic testing as biomarkers of response to antidepressant treatment.
Frieling H; Tadić A
Int Rev Psychiatry; 2013 Oct; 25(5):572-8. PubMed ID: 24151802
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic Brain Network Biomarkers of Antidepressant Response: a Review.
Dunlop K; Talishinsky A; Liston C
Curr Psychiatry Rep; 2019 Aug; 21(9):87. PubMed ID: 31410661
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic-based pharmacotherapies for depression.
Papakostas GI
Eur Neuropsychopharmacol; 2006 Aug; 16(6):391-402. PubMed ID: 16413172
[TBL] [Abstract][Full Text] [Related]
20. Neuronal cell adhesion genes and antidepressant response in three independent samples.
Fabbri C; Crisafulli C; Gurwitz D; Stingl J; Calati R; Albani D; Forloni G; Calabrò M; Martines R; Kasper S; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Girolamo GD; Serretti A
Pharmacogenomics J; 2015 Dec; 15(6):538-48. PubMed ID: 25850031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
